Qiang Liu

Fondatore presso Tangent Capital, Inc.

58 anni

Consumer Services

Health Technology

Profilo

Qiang Liu is the founder of Tangent Capital, Inc. (founded in 2006) and holds the title of Managing Director.
He is currently a Director at China Nuokang Bio-Pharmaceutical, Inc. (since 2006).
Mr. Liu was previously the President of BCTech Investments, Inc. (2007-2008).
He holds an MBA from York University (2000), a graduate degree from The University of New South Wales (1996), and an undergraduate degree from Jilin University (1989).

Posizioni attive di Qiang Liu

Società	Posizione	Inizio
China Nuokang Bio-Pharmaceutical, Inc. China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China.	Direttore/Membro del Consiglio	23/11/2009
Tangent Capital, Inc.	Fondatore	13/12/2010

Tutte le posizioni attive di Qiang Liu

Precedenti posizioni note di Qiang Liu

Società	Posizione	Fine
BCTech Investments, Inc.	Presidente	01/12/2008

Vedi nel dettaglio l'esperienza di Qiang Liu

Formazione di Qiang Liu

Jilin University	Undergraduate Degree
The University of New South Wales	Graduate Degree
York University	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Qiang Liu

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
China Nuokang Bio-Pharmaceutical, Inc. China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China.	Health Technology
Tangent Capital, Inc.
BCTech Investments, Inc.

Vedi le connessioni aziendali